Abstract:Regulatory interleukin-10 (IL-10)-producing B cells (B10 cells) play a critical role in preventing and curing autoimmune diseases in experimental mouse models. However, the precise cellular and molecular mechanisms of action of B10 cells in humans, especially in patients with Crohn's disease (CD), remain to be determined. miR-155 regulates many physiological and pathological conditions, including inflammation such as that in CD. In this study, we aimed to explore the effect of miRNA-155 on IL-10 production by B cells in healthy controls (HCs) and CD patients. Interestingly, we found that CD24(hi)CD27(+) B cells express high levels of miRNA-155 and IL-10, which are positively correlated. Additionally, CD24(hi)CD27(+) B cells express higher levels of Toll-like receptor 9 than those found in other B cell subsets. Overexpression of miRNA-155 promotes IL-10 production, while inhibition of miRNA-155 decreases IL-10 production. We determined that miR-155 directly inhibits the expression of Jarid2, which reduces H3K27me3 binding to the IL10 promoter and increases IL-10 gene expression. In coculture systems, the CD24(hi)CD27(+) B cells from HCs suppressed the secretion of TNF alpha and IFN gamma by monocytes and T cells, respectively. However, the number and function of CD24(h)iCD27(+) B cells from CD patients were decreased. Moreover, we found that miR-155 induces CD24(hi)CD27(+) B cells to produce higher levels of TNF alpha instead of IL-10 in CD patients than in the controls and that the increased number of IL-10(+)TNF alpha(+) B cells reduces the induction of Foxp3 expression and the inhibition of IFN gamma production by CD4(+) CD25- T cells, as well as TNF alpha production by monocytes. Our study demonstrates the critical role of miRNA-155 in the regulation of IL-10 production by B cells and reveals the novel molecular mechanism underlying the functional impairment of B10 cells in CD patients. Our study has the potential to drive the development of B10 cell-based strategies to ameliorate disease progression in CD patients.

Constitutively CD40-activated B cells regulate CD8 T cell inflammatory response by IL-10 induction.

Lipopolysaccharide Attenuates CD40 Ligand-Induced Regulatory B10 Cell Expansion and IL-10 Production in Mouse Splenocytes

Prevention of Experimental Colitis in SCID Mice Reconstituted with CD45RBhigh CD4+ T Cells by Blocking the CD40-CD154 Interactions1

B7 Interactions with CD28 and CTLA-4 Control Tolerance or Induction of Mucosal Inflammation in Chronic Experimental Colitis

MicroRNA-10a Negatively Regulates CD4+ T Cell IL-10 Production Through Suppression of Blimp1.

CD40 signaling augments IL-10 expression and the tolerogenicity of IL-10-induced regulatory dendritic cells

Tumor Necrosis Factor Suppresses Interleukin 10 in Peripheral B Cells Via Upregulating Bcl2-like Protein 12 in Patients with Inflammatory Bowel Disease.

CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L. Potential role in regulating helper effector function.

CD40-signalling abrogates induction of RORγt+ Treg cells by intestinal CD103+ DCs and causes fatal colitis

Characterization of novel CD8+ regulatory T cells and their modulatory effects in murine model of inflammatory bowel disease

IL-10-providing B cells govern pro-inflammatory activity of macrophages and microglia in CNS autoimmunity

Negative Regulation of Cd40-Mediated B Cell Responses by E3 Ubiquitin Ligase Casitas-B-Lineage Lymphoma Protein-B

TLR9 mediated regulatory B10 cell amplification following sub-total body irradiation: Implications in attenuating EAE.

IL-10 engages macrophages to shift Th17 cytokine dependency and pathogenicity during T-cell-mediated colitis

Integrin CD11b Attenuates Colitis by Strengthening Src-Akt Pathway to Polarize Anti-Inflammatory IL-10 Expression

Il-10-Independent Regulatory B-Cell Subsets and Mechanisms of Action

IL12p40 regulates functional development of human CD4+ T cells: enlightenment by the elevated expressions of IL12p40 in patients with inflammatory bowel diseases.

Regulation of CD11b by HIF-1α and the STAT3 signaling pathway contributes to the immunosuppressive function of B cells in inflammatory bowel disease.

Antigen-dependent interactions between regulatory B cells and T cells at the T:B border inhibit subsequent T cell interactions with DCs

IL-10 Engages Macrophages to Shift Th17 Cytokine Dependency and Pathogenicity During T Cell-Mediated Colitis (MUC8P.729)

miR-155 Regulates IL-10-Producing CD24 hi CD27 + B Cells and Impairs Their Function in Patients with Crohn's Disease.